CSF YKL-40, along with several complement proteins, were found to be higher in men across the AD clinical spectrum and also in the preclinical stage [4, 36], while other studies did not find differences in CSF YKL-40 [35] or sTREM2 [37]. Here, CHI3L1 is linked to Alzheimer disease.